We first reported SYT7 as an oncogene and a potential diagnostic and prognostic biomarker in HNSCC, thus, SYT7 was considered to be a promising diagnostic and therapeutic target for HNSCC patients. Here, SYT7 is linked to head and neck squamous cell carcinoma.